Clin Genitourin Cancer 2020 Jan 07
Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports.
Suzuki K, Terakawa T, Kimbara S, Toyoda M, Jimbo N, Nakano Y, Minami H, Fujisawa M
Read More
Source: PubMed
Lipids Health Dis
Contribution of Pyk2 pathway and reactive oxygen species (ROS) to the anti-cancer effects of eicosapentaenoic acid (EPA) in PC3 prostate cancer cells.
Oono K, Ohtake K, Watanabe C, Shiba S, Sekiya T, Kasono K
n-3 polyunsaturated fatty acids (n-3 PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are thought to exert protective eff ...
Read More
Source: PubMed
Int. J. Radiat. Oncol. Biol. Phys. 2020 Jan 28
Erectile dysfunction and absorbed dose to penile base structures in a randomized trial comparing ultra-hypofractionated and conventionally fractionated radiotherapy for prostate cancer.
Rasmusson E, Gunnlaugsson A, Wieslander E, Höglund P, Widmark A, Fransson P, Kjellén E, Nilsson P
To study the relationships between absorbed dose to penile base structures and erectile dysfunction (ED) in patients treated with ultra-hypofractionat ...
Read More
Source: PubMed
Am. J. Clin. Pathol. 2020 Jan 31
Prostate-Specific Antigen Test Utilization in a Major Canadian City.
Wang Q, Chen F, Jiang D, Kabani A, Sokoro AAH
To review the utilization of prostate-specific antigen (PSA) testing in Winnipeg, a major Canadian city, and to compare PSA testing rates between Winn ...
Read More
Source: PubMed
J. Urol. 2020 Jan 31
Risk of Postoperative Upstaging or Upgrading Among Men with Low-Risk Familial Prostate Cancer.
Jansson F, Folkvaljon F, Stattin P, Bratt O, Akre O
To investigate whether men with biopsy-verified low-grade cancer and a family history of lethal or advanced prostate cancer are at particularly high r ...
Read More
Source: PubMed
